Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net income (loss) attributable to MariMed Inc. $ (8,242,911) $ 514,760
Net income (loss) attributable to noncontrolling interests 132,520 99,431
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation 253,713 163,410
Equity compensation 6,863,609 19,295
Acquisition of iRollie LLC 600,000
Common stock issued for services 2,466,003 38,965
Loss on preferred stock conversions 34,044
Loss on debt settlements (1,776,960) (18,278)
Loss on common stock issued for services 958,757 18,278
Changes in operating assets and liabilities:    
Accounts receivable, net (1,666,587) (448,183)
Deferred rents receivable (496,908) (67,437)
Due from third parties (1,177,734) (506,900)
Due from related parties (35,108)
Other current assets (44,870) (56,278)
Other assets (577,861) (109,520)
Accounts payable 2,029 889,489
Accrued expenses 246,810 (488,228)
Due to related parties (196,000) 10,280
Net cash provided by (used in) operating activities (27,182) 42,254
Cash flows from investing activities:    
Purchase of property and equipment (5,663,585) (3,766,154)
Investment in promissory note (100,000)
Interest on notes receivable 22,125 25,097
Net cash used in investing activities (5,741,460) (3,741,057)
Cash flows from financing activities:    
Proceeds from subscribed preferred stock 200,000
Proceeds from subscribed common stock 32,833  
Issuance of common stock 8,461,003 5,200,000
Issuance of interest in subsidiary 150,000
Issuance (repayments) of promissory notes (700,000) 400,000
Proceeds from (payments of) mortgages payable, net 1,941,908 (4,728)
Exercise of stock options 39,000
Exercise of warrants 106,618
Distributions (325,825)  
Net cash provided by financing activities 9,555,537 5,945,272
Net change to cash and cash equivalents 3,786,895 2,246,469
Cash and cash equivalents at beginning of period 1,290,231 569,356
Cash and cash equivalents at end of period 5,077,126 2,815,825
Supplemental disclosure of cash flow information:    
Cash paid for interest 553,206 157,930
Cash paid for taxes 12,596
Non-cash activities:    
Equity issued to settle debt $ 1,275,000